Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hiroko Iijma"'
Autor:
Hiroyasu Imanishi, Shuhei Nishiguchi, Akira Muramatsu, Yoshinori Iwata, Hiroshi Kasugai, Yoshihiko Yano, Hirayuki Enomoto, Susumu Imoto, Hiroaki Okushin, Hideji Nakamura, Yasushi Seo, Toshiaki Ninomiya, Hiroko Iijma, Soji Shimomura, Tomoyuki Takashima, Teruji Ooka, Masahiko Sugano, Masaki Saito, Michiko Shindo, Soo Ryang Kim, Hisato Jomura, Nobuhiro Aizawa
Publikováno v:
Hepatology Research. 44:597-607
Aim The recommended treatment for chronic hepatitis C is a combination of pegylated interferon (PEG IFN) plus ribavirin (RBV). However, the sustained virological response (SVR) rate of PEG IFN-RBV therapy was approximately 50% in patients with genoty
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 73
Autor:
Yoshiyuki Sakai, Akio Ishii, Hirayuki Enomoto, Naoto Ikeda, Shuhei Nishiguchi, Yoshinori Iwata, Hironori Tanaka, Nobuhiro Aizawa, Tomoyuki Takashima, Hiroko Iijma, Chisa Kuga, Masaki Saito
Publikováno v:
Biochemical and biophysical research communications. 454(3)
Although the development of anti-interferon (IFN)-α neutralizing antibodies (NAbs) is likely to be a common clinical problem for patients with various diseases treated with IFN, anti-IFN-α NAb has been exceptionally considered to have no clinical s